The deal values Integer at $5.7bn, a 51.8% premium to its share price before a strategic review was announced in April 2026.
KKR will acquire Integer Holdings in an all-cash transaction valuing the company at $5.7bn, or $127 per share. The offer marks a 51.8% premium to Integer’s closing price on 29 April 2026, the day before it announced a strategic review.
Integer’s board unanimously approved the deal, which follows a months-long review of alternatives. The 28.8% premium to the 30-day volume-weighted average price as of 31 July 2026 reflects strong investor interest. The company had explored multiple options before selecting KKR’s bid.
Integer CEO Payman Khales called the transaction an “exciting milestone,” citing KKR’s healthcare expertise and long-term vision. Shareholders will vote on the agreement, which aims to deliver immediate value.